TESARO announces European Commission approval of ZEJULA® for Women with Recurrent Ovarian Cancer
TESARO announced that the European Commission (EC) has granted marketing authorization for ZEJULA®(niraparib) as a monotherapy for the maintenance treatment of adult patients with…
Read More...
Read More...